These results, albeit in a small cohort, suggest that patients with type 2 diabetes and LVH may be able to be more precisely stratified for risk of the development of heart failure according to their KLF15 rs9838915 genotype. This evidence concerns the gene KLF15 and type 2 diabetes mellitus.